Distribuzione geografica
Continente #
NA - Nord America 18.533
EU - Europa 1.387
AS - Asia 449
OC - Oceania 12
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 20.393
Nazione #
US - Stati Uniti d'America 18.506
CN - Cina 308
IT - Italia 290
IE - Irlanda 268
UA - Ucraina 197
DE - Germania 193
FR - Francia 152
GB - Regno Unito 98
KR - Corea 59
FI - Finlandia 47
SE - Svezia 40
PL - Polonia 27
BE - Belgio 24
RU - Federazione Russa 22
CA - Canada 20
VN - Vietnam 19
AU - Australia 11
IR - Iran 11
SG - Singapore 11
HK - Hong Kong 10
IN - India 10
UZ - Uzbekistan 9
MX - Messico 7
AT - Austria 5
ES - Italia 5
RO - Romania 5
BR - Brasile 4
SI - Slovenia 4
BD - Bangladesh 3
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
JP - Giappone 2
MA - Marocco 2
NL - Olanda 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
CH - Svizzera 1
CL - Cile 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.393
Città #
Wilmington 5.505
Houston 4.783
Woodbridge 4.462
Fairfield 634
Ann Arbor 527
Chandler 426
Ashburn 317
Seattle 247
Dublin 223
Cambridge 212
Medford 177
Jacksonville 150
New York 119
Rome 116
Beijing 94
Dearborn 87
Lawrence 83
Zhengzhou 57
Redwood City 49
San Diego 36
Seoul 28
Kraków 27
Menlo Park 27
Chengdu 26
Nanjing 24
Brussels 23
London 19
Dong Ket 18
Shenzhen 17
Mülheim 16
Shanghai 15
Toronto 15
Palo Alto 14
Boardman 13
Norwalk 13
Bassano del Grappa 12
Hefei 12
Leawood 12
Milan 12
Augusta 11
Center 11
Los Angeles 11
Mountain View 11
Kunming 10
Buffalo 8
Hong Kong 8
Phoenix 8
San Mateo 8
Scottsdale 8
Esslingen am Neckar 7
Guangzhou 7
Helsinki 6
Mexico City 6
San Francisco 6
Chicago 5
Padova 5
Singapore 5
Sydney 5
Wuhan 5
Ardabil 4
Aversa 4
Brisbane 4
Durham 4
Falls Church 4
Fuzhou 4
Jinan 4
Kilburn 4
Lappeenranta 4
Napoli 4
Novi Velia 4
Pune 4
Redmond 4
Abbadia San Salvatore 3
Acton 3
Baotou 3
Changsha 3
Chieti 3
Dhaka 3
Hounslow 3
Indiana 3
Livorno 3
Montreal 3
Nanchang 3
Rensselaer 3
San Jose 3
Shenyang 3
St. George 3
Tivoli 3
Trieste 3
Triggiano 3
Verona 3
Amantea 2
Casalzuigno 2
Castelfranco Veneto 2
Catanzaro 2
Cecina 2
Chongqing 2
Colorado Springs 2
Costa Mesa 2
Creede 2
Totale 18.925
Nome #
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 472
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 440
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 430
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 422
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 419
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 414
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 404
Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. 403
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 402
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 402
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 402
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 401
Seronegative autoimmune diseases 393
The type I IFN system in rheumatoid arthritis 390
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. 390
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 385
Identifying the cells breaching self-tolerance in autoimmunity. 383
Autoantibodies in inflammatory arthritis 383
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres 381
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. 375
Lymph node IL-18 expression in adult-onset Still's disease. 374
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 369
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 367
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 366
The interplay between inflammation and metabolism in rheumatoid arthritis 363
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 361
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 359
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 356
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 348
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 345
Insights on the role of physical activity in patients with rheumatoid arthritis 342
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 341
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate 338
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation 337
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. 335
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 309
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 305
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 298
Histopathology of the skin in rheumatic diseases 287
null 287
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 286
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. 285
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 285
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 266
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 265
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 239
Interaction between microbiome and host genetics in psoriatic arthritis 230
Challenges in the treatment of Rheumatoid Arthritis 226
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 212
Complement, infection, and autoimmunity 201
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 191
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 175
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 174
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 172
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 168
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 159
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 153
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 150
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 149
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 146
Severe lupus nephritis: an unexpected association with Fabry disease 121
Immune checkpoint inhibitors-induced autoimmunity: The impact of gender 114
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing 113
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 108
COVID-19: disCOVering the role of complement system 107
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 106
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 93
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 93
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 93
Gender equality in Rheumatology 92
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 92
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 91
Tackling the autoimmune side in Spondyloarthritis: a systematic review 91
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 76
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 41
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 28
Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations 27
Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome 26
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 26
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 23
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 18
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 18
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 18
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib 18
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 16
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 15
The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors 14
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 13
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 12
Subclinical signs of retinal involvement in hereditary angioedema 11
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study 10
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 9
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 9
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 8
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE 8
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 7
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 7
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 7
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 6
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 5
Totale 20.800
Categoria #
all - tutte 43.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.553

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019961 0 0 0 0 0 0 0 0 0 0 481 480
2019/20205.865 394 396 337 415 447 748 514 563 588 599 426 438
2020/20214.731 440 589 507 552 570 498 612 479 186 115 139 44
2021/2022861 37 82 75 58 29 50 40 48 46 66 94 236
2022/20231.184 109 99 40 139 103 261 109 89 118 23 66 28
2023/2024481 60 17 22 15 68 133 15 87 26 20 18 0
Totale 20.825